Author: OurCrowd

[Alpha Tau in GlobeNewswire] Alpha Tau announces highly promising interim results from safety and feasibility trial of Alpha DaRT treatment of advanced pancreatic cancer

Nov 28, 2023 |

JERUSALEM, Nov. 28, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the release of interim results from treatment of the first five patients in the Company’s safety and feasibility trial examining the use of Alpha DaRT to treat advanced pancreatic cancer, currently underway at two university hospitals in Montreal, Canada. Read...

Read More

[Stellar Cyber in Business Wire] Stellar Cyber named as a Representative Vendor in the Gartner® Hype Cycle™ for Midsize Enterprises, 2023 for XDR Platforms

Nov 27, 2023 |

SAN JOSE, Calif.–(BUSINESS WIRE)–Stellar Cyber, the innovator of Open XDR technology, has been included as a Representative Vendor in the Gartner report, Hype Cycle for Midsize Enterprises, 2023. The report details, “Effective investments in technology are among the most substantive ways to augment the limited capabilities of resource-constrained midsize enterprises. This Hype Cycle helps MSE technology leaders identify and strategically apply technology solutions to execute against business and IT priorities.” In its section on XDR platforms, the report says, “purchasing a systemic detection stack in the form of XDR can simplify product selection and acquisition.” Read more...

Read More